Of note, the double knockdown of YY1 and MYC consistently showed low cancer scores after perturbations in the majority of cases (Figure 4i and Table S3, Supporting Information), confirming that the combination of YY1 and MYC may exhibit synergistic effects, rendering them promising target genes for cancer reversion. Here, MYC is linked to cancer.